| Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder (NCT07704762) | U.S. Army Medical Research and Development Command | 2026-10-01 |
| Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults (NCT06205056) | U.S. Army Medical Research and Development Command | 2024-01-30 |
| Treatment of Hemorrhagic Fever With Ribavirin (NCT04283513) | U.S. Army Medical Research and Development Command | 2022-10-31 |
| Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults (NCT05423418) | U.S. Army Medical Research and Development Command | 2022-09-08 |
| Single or Repeat Dose of G03-52-01 in Adult Subjects (NCT05348993) | U.S. Army Medical Research and Development Command | 2022-06-15 |
| HIV Vaccine in HIV-uninfected Adults (NCT04658667) | U.S. Army Medical Research and Development Command | 2022-02-03 |
| Safety/Immunogenicity Hantaan Virus DNA Vaccine and Puumala Virus DNA Vaccine, For Prevention of HFRS (NCT04333459) | U.S. Army Medical Research and Development Command | 2021-08-23 |
| FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4) (NCT03867162) | U.S. Army Medical Research and Development Command | 2021-06-09 |
| Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults (NCT03531242) | U.S. Army Medical Research and Development Command | 2021-06-01 |
| PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 (NCT04784767) | U.S. Army Medical Research and Development Command | 2021-04-05 |
| A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy Adults (NCT04296279) | U.S. Army Medical Research and Development Command | 2020-03-20 |
| A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults (NCT04268420) | U.S. Army Medical Research and Development Command | 2020-03-20 |
| A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI) (NCT04203186) | U.S. Army Medical Research and Development Command | 2020-03-01 |
| Combination HTNV and PUUV DNA Vaccine (NCT03718130) | U.S. Army Medical Research and Development Command | 2019-07-10 |
| An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample (NCT04180930) | U.S. Army Medical Research and Development Command | 2019-04-15 |
| Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54 (NCT03882528) | U.S. Army Medical Research and Development Command | 2019-03-04 |
| Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine (NCT03609398) | U.S. Army Medical Research and Development Command | 2018-10-04 |
| Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis (NCT03278808) | U.S. Army Medical Research and Development Command | 2018-09-17 |
| Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Malaria Infection in Malaria Naïve Adults (NCT03341754) | U.S. Army Medical Research and Development Command | 2018-09-15 |
| Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults (NCT03051386) | U.S. Army Medical Research and Development Command | 2018-05-30 |
| Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated Vaccine (NCT03141138) | U.S. Army Medical Research and Development Command | 2017-11-08 |
| ID Recombinant Ricin Toxin A-Chain Vaccine RVEc™ - 3-Dose Primary Series With Boost (NCT02386150) | U.S. Army Medical Research and Development Command | 2017-10-01 |